TAS-205一水合物

TAS-205 monohydrate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1584160-52-0

中文名称

TAS-205一水合物

英文名称

TAS-205 monohydrate

别名

TAS 205;4-[(1-methyl-1H-pyrrol-2-yl)carbonyl]-N-[4-[4-(4-morpholinylcarbonyl)-1-piperidinyl]phenyl]-1-piperazinecarboxamide, monohydrate;1-Piperazinecarboxamide, 4-[(1-methyl-1H-pyrrol-2-yl)carbonyl]-N-[4-[4-(4-morpholinylcarbonyl)-1-piperidinyl]phenyl]-, hydrate (1:1)

标准英文名

4-(1-methyl-1H-pyrrole-2-carbonyl)-N-(4-(4-(morpholine-4-carbonyl)piperidin-1-yl)phenyl)piperazine-1-carboxamide hydrate

分子式

C27H38N6O5

分子量

526.64

精确分子量

526.29

SMILES

O=C(N1CCN(C(C2=CC=CN2C)=O)CC1)NC3=CC=C(N4CCC(C(N5CCOCC5)=O)CC4)C=C3.[H]O[H]

标准SMILES

O.CN1C=CC=C1C(=O)N1CCN(CC1)C(=O)NC1C=CC(=CC=1)N1CCC(CC1)C(=O)N1CCOCC1

用途

TAS-205 is a hematopoietic prostaglandin D synthase (HPGDS) inhibitor that selectively suppresses prostaglandin D2 (PGD2) synthesis in cellular enzymatic assays and in vivo models, effectively reducing eosinophil infiltration into the nasal cavity and late-phase nasal congestion; it exhibits significant synergistic inhibitory effects when combined with montelukast (HY-13315A), and shows moderate inhibitory effects on both early- and late-phase nasal congestion when co-administered with fexofenadine (HY-B0801A).

InChIKey

NFXCKTKGAJDCBA-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  1584160-52-0 逆合成路线 1

—
—
—
—
ACGVNM429
1584160-52-0
来源: SureRoute

2.  1584160-52-0 逆合成路线 2

ACFAMI375
6973-60-0
—
—
ACGVNM429
1584160-52-0
来源: SureRoute

3.  1584160-52-0 逆合成路线 3

—
—
—
—
ACGVNM429
1584160-52-0
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手